Thurston Springer Miller Herd & Titak’s GSK GSK Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.15K	Hold	60	–	–	﹤0.01%	1046
2026 Q1	$3.31K	Hold	60	–	–	﹤0.01%	1112
2025 Q4	$2.94K	Buy	+60	New	+$2.8K	﹤0.01%	1171
2025 Q3	–	Sell	-46	Closed	-$1.77K	–	883
2025 Q2	$1.77K	Hold	46	–	–	﹤0.01%	1437
2025 Q1	$1.78K	Hold	46	–	–	﹤0.01%	1457
2024 Q4	$1.55K	Sell	46 -56	-55%	-$2.02K	﹤0.01%	1160
2024 Q3	$4.17K	Hold	102	–	–	﹤0.01%	1231
2024 Q2	$3.93K	Buy	+102	New	+$4.29K	﹤0.01%	1222

Other funds holding GSK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

KIC

Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

AWAG

ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return

HAI

Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's GSK Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its GSK (GSK) position steady in Q2 2026 at 60 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Thurston Springer Miller Herd & Titak first reported a position in GSK in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.17K in Q3 2024. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Thurston Springer Miller Herd & Titak held 60 shares of GSK worth $3.15K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1046 holding.
Thurston Springer Miller Herd & Titak first reported a position in GSK in Q2 2024 and has held it in 8 quarters since.
Thurston Springer Miller Herd & Titak's GSK position peaked at $4.17K in Q3 2024.
161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.